Abstract
The combination of machine learning (ML) techniques and neuromarkers/biomarkers for improved prognosis of Alzheimer’s diseases (AD) and mild cognitive impairment (MCI) has received increasing attentions in the community. The first part of this chapter is devoted to reviewing the recently emerged ML algorithms for dementia diagnosis, based on electroencephalography (EEG) and magnetoencephalography (MEG) modalities. In particular, the ML approaches are systematically categorized by the types of neuromarkers employed. The second part of the chapter is dedicated to a case study based investigation, to highlight the differences between these two modalities in the well-recognized resting status data collection scenario. A number of the most recent reports on MCI/AD detections during resting state using EEG/MEG are documented to show the up-to-date performance. It is noticed that the MEG modality may be particularly effective for MCI detection, a high classification accuracy of more than 98% was reported recently; whereas the EEG seems to be performing well in classifying AD and healthy subjects, which also reached around 98% of the accuracy. A number of influential factors have also been raised and suggested for careful considerations while evaluating the ML-based diagnosis systems in the real-world scenarios.
Original language | English |
---|---|
Title of host publication | Machine Learning in Medicine |
Editors | Ayman El-Baz, Jasjit Suri |
Place of Publication | Boca Raton |
Publisher | Taylor & Francis Group |
Chapter | 8 |
Number of pages | 14 |
Edition | 1st |
ISBN (Electronic) | 9781315101323 |
DOIs | |
Publication status | Published (in print/issue) - 4 Aug 2021 |
Keywords
- Alzheimer's disease,
- artificial intelligence,
- machine learning,
- magnetoencephalograph,,
- neuromarkers,
- data analytics